View this issue as a PDF (This is a large file that may take some time to load.)

Cover Story

• Novel Mechanism of Regulation of Hepcidin and Iron Homeostasis

Diffusion

• Dendritic Cells Inflamed by Coagulation
• Increased Risk of VTE Associated With Impaired Clot Lysis: A New Dimension to Virchow's Triad
• The "Eyes"(and Kidneys) Have It: A promoter polymorphism of the erythropoietin gene associated with proliferative diabetic retinopathy and end-stage renal disease
• Gene Addiction in Myeloma
• MDM2 SNP May Be Important in Predicting Outcome of CLL Patients
• Home Sweet Home
• Pit Stop in the Liver for Primitive Erythrocytes to Enucleate
• Myelodysplastic Syndromes: Will WHO classification and WPSS become tools for hematopoietic stem cell

Letters to the Editor

News and Reports

• NHLBI's Realignment of Sickle Cell Program Brings Difficult Change, But Also Raises Hopes for Needed Progress
• ASH Seeks to Expand Collaborations With Patient Advocacy Groups
• ASH Recognized on U.S. House of Representatives Floor for the Research, Treatment, and Advocacy of Sickle Cell Disease
• W. Keith Hoots, MD, to Lead Division of Blood Diseases and Resources
• Election Ballots Due September 30
• Important Annual Meeting Dates
• Tuesday Sessions at 2008 Annual Meeting

The Hematologist-in-Training

• The Evolution of the Hematology Fellowship
• The Second Time Around

The Hematologist Advocate

• Hematologists on the Hill: ASH Committee on Practice Meets With Members of Congress
• Disability Issues Give Presidential Campaign a New Spin
• Headlines From Washington

The Hematologist Researcher

• ASH Works With NIH to Clarify and Improve Policy on Enhanced Access

Profiles in Hematology

• Samuel I. Rapaport: Unsung Hero of Blood Coagulation